“The Relationship between Interleukin 6 (IL-6) Levels and Disease Activity (SLEDAI-2K) and Manifestations of Renal and Non-Renal Damage in Patients with Systemic Lupus Erythematosus: Research” (2026) Cermin Dunia Kedokteran, 53(01), pp. 6–11. doi:10.55175/cdk.v53i01.1596.